Hinge Health Projects Q2 Revenue of $200M-$202M
Reported by Dow Jones Newswires
Sentiment
Neutral
Importance
8
Price
$64.74
Mkt Cap
$4.858B
52W Low
$30.08
52W High
$66.55
Market data snapshot near publication time
Summary
Hinge Health projects Q2 revenue to be between $200 million and $202 million. This guidance follows the company's strong Q1 2026 results reported on May 5th, which saw revenue of $182.31 million and a raised full-year outlook. The projected sequential growth from Q1 to Q2 is a key indicator for traders assessing the company's ongoing performance and momentum.
At the time of this announcement, HNGE was trading at $64.74 on NYSE in the Technology sector, with a market capitalization of approximately $4.9B. The 52-week trading range was $30.08 to $66.55. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.
Price Chart
HNGE - Latest Insights
HNGE
Jun 09, 2026, 4:06 PM EDT
Price at Filing:
$64.01
Real-time Price:
$65.23
Change:
+$1.22 (+2%)
Market Cap:
$5.056B
HNGE
Jun 09, 2026, 4:06 PM EDT
Price at Filing:
$64.74
Real-time Price:
$65.23
Change:
+$0.490 (+0.76%)
Market Cap:
$5.056B
HNGE
May 05, 2026, 4:32 PM EDT
Price at Filing:
$53.89
Real-time Price:
$65.23
Change:
+$11.34 (+21%)
Market Cap:
$5.056B
HNGE
May 05, 2026, 4:06 PM EDT
Price at Filing:
$54.03
Real-time Price:
$65.23
Change:
+$11.20 (+21%)
Market Cap:
$5.056B
HNGE
Mar 17, 2026, 4:06 PM EDT
Price at Filing:
$44.15
Real-time Price:
$65.23
Change:
+$21.08 (+48%)
Market Cap:
$5.056B
HNGE
Feb 12, 2026, 4:51 PM EST
Price at Filing:
$39.85
Real-time Price:
$65.23
Change:
+$25.38 (+64%)
Market Cap:
$5.056B
HNGE
Feb 10, 2026, 4:07 PM EST
Price at Filing:
$34.65
Real-time Price:
$65.23
Change:
+$30.58 (+88%)
Market Cap:
$5.056B